Nanotechnology delivers hepatitis B vaccine

Brazilian and European researchers have demonstrated exactly how a nanotechnology-based compound delivers an oral vaccine against hepatitis B to the immune system. When particles containing silica and an antigen combine, even though they are different sizes, they reach the intestine without being destroyed by the acidity of the digestive system. A compound of nanostructured SBA-15…

Drug companies’ sexually explicit ads reaching too many youngsters

Virtually every day, millions of children and adolescents are being bombarded by sexually explicit direct-to-consumer advertising, despite pharmaceutical CEOs’ claims to the contrary. Leading business ethicist Denis Arnold from the University of North Carolina at Charlotte co-authored the study, “Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials,” published…

Clemson researchers tie metabolic enzyme to obesity and fatty liver disease

IMAGE: Clemson University graduate student Melissa Heintz and professor William Baldwin recently published their collaborative research in the Journal of Nutritional Biochemistry. view more  Credit: Pete Martin / College of Science CLEMSON, South Carolina – Researchers from Clemson University’s Environmental Toxicology Program have published research connecting an enzyme associated with detoxification to obesity and fatty liver…